Sarah Boyce
2019 - Avidity Biosciences
In 2019, Sarah Boyce earned a total compensation of $4.4M as President and Chief Executive Officer at Avidity Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $50,630 |
|---|---|
| Option Awards | $4,295,649 |
| Salary | $103,512 |
| Other | $117 |
| Total | $4,449,908 |
Boyce received $4.3M in option awards, accounting for 97% of the total pay in 2019.
Boyce also received $50.6K in non-equity incentive plan, $103.5K in salary and $117 in other compensation.
Rankings
In 2019, Sarah Boyce's compensation ranked 2,583rd out of 13,971 executives tracked by ExecPay. In other words, Boyce earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,583 out of 13,971 | 82nd |
Division Manufacturing | 924 out of 5,701 | 84th |
Major group Chemicals And Allied Products | 302 out of 2,200 | 86th |
Industry group Drugs | 243 out of 1,886 | 87th |
Industry Pharmaceutical Preparations | 177 out of 1,398 | 87th |
Source: SEC filing on April 29, 2021.